Europe Bariatric Surgery Market Forecast 2024-2032

List of Tables

KEY FINDINGS

The Europe bariatric surgery market is expected to record a CAGR of 5.30% during the forecast period, 2024-2032. The rising burden of obesity is boosting the market growth in the region.

MARKET INSIGHTS

Belgium, Poland, Germany, the United Kingdom, Spain, France, Italy, and Rest of Europe are evaluated for the Europe bariatric surgery market growth analysis. As lifestyles have become more sedentary and dietary habits have shifted, the incidence of obesity has surged in Europe, necessitating the demand for effective treatment options such as bariatric surgery.

Countries within Europe, including the United Kingdom, Germany, France, Italy, Spain, Belgium, and Poland, have seen a rise in the adoption of bariatric procedures as both patients and healthcare providers recognize the long-term benefits in terms of weight management and improvement in comorbid conditions such as diabetes and cardiovascular diseases.

Advancements in surgical techniques and technologies, including minimally invasive procedures and robotic-assisted surgeries, have contributed to the market's growth by enhancing patient outcomes, reducing hospital stays, and minimizing post-operative complications. Moreover, increased awareness campaigns, coupled with favorable reimbursement policies in many European countries, have further fueled the expansion of the bariatric surgery market.

As the prevalence of obesity continues to escalate, the European bariatric surgery market is projected to experience sustained growth in the coming years. However, challenges such as healthcare infrastructure disparities among European nations and regulatory hurdles may pose obstacles to market expansion.

COMPETITIVE INSIGHTS

Some of the esteemed players operating in the market are Medtronic PLC, Allergan Inc, Intuitive Surgical Inc, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 82568

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
- 2.4.1. IMPACT ANALYSIS OF COVID-19
2.5. MAJOR MARKET FINDING
- 2.5.1. GROWING ADOPTION OF MINIMALLY INVASIVE PROCEDURES DUE TO SHORTER HOSPITAL STAYS

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. INCREASING AVAILABILITY AND AFFORDABILITY OF BARIATRIC PROCEDURES
- 3.1.2. RISING RATES OF OBESITY AND ASSOCIATED HEALTH RISKS PROPEL DEMAND FOR WEIGHT LOSS PROCEDURES
- 3.1.3. TECHNOLOGICAL ADVANCES ENABLE SAFER AND LESS INVASIVE PROCEDURES
3.2. KEY RESTRAINTS
- 3.2.1. COMPLICATIONS AND MORTALITY RISKS REQUIRING INTENSIVE FOLLOW-UP CARE
- 3.2.2. LIMITED INSURANCE COVERAGE IN SOME HEALTHCARE MARKETS

4. KEY ANALYTICS

4.1. KEY TECHNOLOGY TRENDS
- 4.1.1. SHIFT TOWARDS LESS INVASIVE LAPAROSCOPIC PROCEDURES OVER OPEN SURGERIES
- 4.1.2. DEVELOPMENT OF GASTROINTESTINAL SUTURE DEVICES FOR IMPROVED TISSUE APPROXIMATION
- 4.1.3. USE OF PREOPERATIVE 3D MODELING TO PLAN PROCEDURES MORE PRECISELY
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING FOR UNITED KINGDOM
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
4.6. VALUE CHAIN ANALYSIS
- 4.6.1. SUPPLY CHAIN MANAGEMENT AND INTEGRATION
- 4.6.2. DISTRIBUTION STRATEGIES AND RETAIL NETWORKS
- 4.6.3. TECHNOLOGICAL ADVANCEMENTS AND RESEARCH & DEVELOPMENT
- 4.6.4. POST-OPERATIVE CARE AND PATIENT SUPPORT
4.7. KEY PROCURING FACTORS
- 4.7.1. SURGICAL EFFICACY AND OUTCOMES
- 4.7.2. INNOVATIVE PROCEDURAL TECHNIQUES
- 4.7.3. SURGEON PROFICIENCY AND EXPERTISE
- 4.7.4. COMPLIANCE WITH MEDICAL GUIDELINES AND SAFETY STANDARDS

5. MARKET BY DEVICE

5.1. ASSISTING DEVICES
- 5.1.1. MARKET FORECAST FIGURE
- 5.1.2. SEGMENT ANALYSIS
5.2. IMPLANTABLE DEVICES
- 5.2.1. MARKET FORECAST FIGURE
- 5.2.2. SEGMENT ANALYSIS

6. MARKET BY PROCEDURE

6.1. GASTRIC SLEEVE SURGERY
- 6.1.1. MARKET FORECAST FIGURE
- 6.1.2. SEGMENT ANALYSIS
6.2. BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH
- 6.2.1. MARKET FORECAST FIGURE
- 6.2.2. SEGMENT ANALYSIS
6.3. ADJUSTABLE GASTRIC BAND
- 6.3.1. MARKET FORECAST FIGURE
- 6.3.2. SEGMENT ANALYSIS
6.4. GASTRIC BYPASS
- 6.4.1. MARKET FORECAST FIGURE
- 6.4.2. SEGMENT ANALYSIS

7. MARKET BY END-USER

7.1. HOSPITALS
- 7.1.1. MARKET FORECAST FIGURE
- 7.1.2. SEGMENT ANALYSIS
7.2. AMBULATORY SURGICAL CENTERS
- 7.2.1. MARKET FORECAST FIGURE
- 7.2.2. SEGMENT ANALYSIS
7.3. BARIATRIC SURGERY CLINICS
- 7.3.1. MARKET FORECAST FIGURE
- 7.3.2. SEGMENT ANALYSIS

8. GEOGRAPHICAL ANALYSIS

8.1. EUROPE
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. EUROPE BARIATRIC SURGERY MARKET DRIVERS
- 8.1.3. EUROPE BARIATRIC SURGERY MARKET CHALLENGES
- 8.1.4. EUROPE BARIATRIC SURGERY MARKET REGULATORY FRAMEWORK
- 8.1.5. KEY PLAYERS IN EUROPE BARIATRIC SURGERY MARKET
- 8.1.6. COUNTRY ANALYSIS
  - 8.1.6.1. UNITED KINGDOM
  - 8.1.6.1.1. UNITED KINGDOM BARIATRIC SURGERY MARKET SIZE & OPPORTUNITIES
  - 8.1.6.2. GERMANY
  - 8.1.6.2.1. GERMANY BARIATRIC SURGERY MARKET SIZE & OPPORTUNITIES
  - 8.1.6.3. FRANCE
  - 8.1.6.3.1. FRANCE BARIATRIC SURGERY MARKET SIZE & OPPORTUNITIES
  - 8.1.6.4. ITALY
  - 8.1.6.4.1. ITALY BARIATRIC SURGERY MARKET SIZE & OPPORTUNITIES
  - 8.1.6.5. SPAIN
  - 8.1.6.5.1. SPAIN BARIATRIC SURGERY MARKET SIZE & OPPORTUNITIES
  - 8.1.6.6. BELGIUM
  - 8.1.6.6.1. BELGIUM BARIATRIC SURGERY MARKET SIZE & OPPORTUNITIES
  - 8.1.6.7. POLAND
  - 8.1.6.7.1. POLAND BARIATRIC SURGERY MARKET SIZE & OPPORTUNITIES
  - 8.1.6.8. REST OF EUROPE
  - 8.1.6.8.1. REST OF EUROPE BARIATRIC SURGERY MARKET SIZE & OPPORTUNITIES

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIP & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. USGI MEDICAL INC
  - 9.2.1.1. COMPANY OVERVIEW
  - 9.2.1.2. PRODUCT LIST
  - 9.2.1.3. STRENGTHS & CHALLENGES
- 9.2.2. JOHNSON & JOHNSON
  - 9.2.2.1. COMPANY OVERVIEW
  - 9.2.2.2. PRODUCT LIST
  - 9.2.2.3. STRENGTHS & CHALLENGES
- 9.2.3. APOLLO ENDOSURGERY INC.
  - 9.2.3.1. COMPANY OVERVIEW
  - 9.2.3.2. PRODUCT LIST
  - 9.2.3.3. STRENGTHS & CHALLENGES
- 9.2.4. OLYMPUS CORPORATION
  - 9.2.4.1. COMPANY OVERVIEW
  - 9.2.4.2. PRODUCT LIST
  - 9.2.4.3. STRENGTHS & CHALLENGES
- 9.2.5. MEDTRONIC PLC
  - 9.2.5.1. COMPANY OVERVIEW
  - 9.2.5.2. PRODUCT LIST
  - 9.2.5.3. STRENGTHS & CHALLENGES
- 9.2.6. INTUITIVE SURGICAL INC.
  - 9.2.6.1. COMPANY OVERVIEW
  - 9.2.6.2. PRODUCT LIST
  - 9.2.6.3. STRENGTHS & CHALLENGES
- 9.2.7. ALLERGAN INC
  - 9.2.7.1. COMPANY OVERVIEW
  - 9.2.7.2. PRODUCT LIST
  - 9.2.7.3. STRENGTHS & CHALLENGES
- 9.2.8. B. BRAUN MELSUNGEN AG
  - 9.2.8.1. COMPANY OVERVIEW
  - 9.2.8.2. PRODUCTS LIST
  - 9.2.8.3. STRENGTHS & CHALLENGES
- 9.2.9. CONMED CORPORATION
  - 9.2.9.1. COMPANY OVERVIEW
  - 9.2.9.2. PRODUCT LIST
  - 9.2.9.3. STRENGTHS & CHALLENGES
- 9.2.10. MEDIFLEX SURGICAL PROCEDURES
  - 9.2.10.1. COMPANY OVERVIEW
  - 9.2.10.2. PRODUCTS LIST
  - 9.2.10.3. STRENGTHS & CHALLENGES
- 9.2.11. GI DYNAMICS INC
  - 9.2.11.1. COMPANY OVERVIEW
  - 9.2.11.2. PRODUCT LIST
  - 9.2.11.3. STRENGTHS & CHALLENGES
- 9.2.12. ASENSUS SURGICAL US INC
  - 9.2.12.1. COMPANY OVERVIEW
  - 9.2.12.2. PRODUCTS LIST
  - 9.2.12.3. STRENGTHS & CHALLENGES
- 9.2.13. COUSIN SURGERY
  - 9.2.13.1. COMPANY OVERVIEW
  - 9.2.13.2. PRODUCT LIST
  - 9.2.13.3. STRENGTHS & CHALLENGES
- 9.2.14. SPATZ FIGA INC
  - 9.2.14.1. COMPANY OVERVIEW
  - 9.2.14.2. PRODUCT LIST
  - 9.2.14.3. STRENGTHS & CHALLENGES
- 9.2.15. ABBOTT LABORATORIES
  - 9.2.15.1. COMPANY OVERVIEW
  - 9.2.15.2. PRODUCT LIST
  - 9.2.15.3. STRENGTHS & CHALLENGES
- 9.2.16. RICHARD WOLF GMBH
  - 9.2.16.1. COMPANY OVERVIEW
  - 9.2.16.2. PRODUCT LIST
  - 9.2.16.3. STRENGTHS & CHALLENGES